Headache and Facial Pain

Textbook of Clinical Neurology: Third Edition

Volumn , Issue , 2007, Pages 1245-1266

  Silberstein, Stephen D ^a,b   Young, William B ^c  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

^c JEFFERSON HEADACHE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84902042348     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-141603618-0.10053-0     Document Type: Chapter

References (177)

1. Silberstein SD, Silberstein MM Clinical symptomatology and differential diagnosis of migraine. Headache: Diagnosis and Treatment 1993, 59-75. Williams & Wilkins, Baltimore. C.D. Tollison, R.S. Kunkel (Eds.).
2. Critchley M Migraine: From Cappadocia to Queen Square 1967, Heinemann, London.
3. Sacks O Migraine: Understanding a Common Disorder 1985, University of California Press, Berkeley, CA.
4. Liveing E On Megrim, Sick Headache, and Some Allied Disorders: A Contribution to the Pathology of Nerve-Storms 1873, Churchill, London.
5. Classification and diagnostic criteria for headache disorders, cranial neuralgia, and facial pain. Cephalalgia 1988, 8:1-96. Headache Classification Committee of the International Headache Society.
6. The International Classification of Headache Disorders, 2nd ed. Cephalalgia 2004, 24:1-160. Headache Classification Committee.
7. Wolff HG Headache and Other Head Pain 1963, Oxford University, New York.
8. Olesen J, Friberg L, Skyhoj-Olsen T Timing and topography of cerebral blood flow, aura and headache during migraine attacks. Ann Neurol 1990, 28:791-798.
9. Sanchez-del Rio M, Bakker D, Wu O, et al. Perfusion weighted imaging during migraine: Spontaneous visual aura and headache. Cephalalgia 1999, 19:701-707.
10. Cutrer FM, Sorenson AG, Weisskoff RM, et al. Perfusion-weighted imaging defects during spontaneous migrainous aura. Ann Neurol 1998, 43:25-31.
11. Hadjikhani N, delRio M Sanchez, Wu O, et al. Mechanisms of migraine aura revealed by functional MRI in human visual cortex. Proc Nat Acad Sci USA 2001, 98:4687-4692.
12. Pietrobon D, Striessnic J Neurobiology of migraine. Nat Rev Neurosci 2003, 4:386-398.
13. Lashley KS Patterns of cerebral integration indicated by the scotomas of migraine. Arch Neurol 1941, 46:331-339.
14. Leão AAP Spreading depression of activity in cerebral cortex. J Neurophysiol 1944, 7:359-390.
15. Olesen J, Larsen B, Lauritzen M Focal hyperemia followed by spreading oligemia and impaired activation of RCBF in classic migraine. Ann Neurol 1981, 9:344-352.
16. Milner PM Note on a possible correspondence between the scotomas of migraine and spreading depression of Leão. Electroencephalogr Clin Neurophysiol 1958, 10:705.
17. Cao Y, Welch KM, Aurora S, Vikingstad EM Functional MRI-BOLD of visually triggered headache in patients with migraine. Arch Neurol 1999, 56:548-554.
18. Andersen AR, Friberg L, Skyloj-Olsen T, Olesen J Delayed hyperemia following hypoperfusion in classic migraine. Single photon emission tomographic demonstration. Arch Neurol 1988, 45:154-159.
19. Seto H, Shimizu M, Futatsuya R, et al. Basilar artery migraine. Reversible ischemia demonstrated by Tc-99m HMPAO brain SPECT. Clin Nucl Med 1994, 19:215-218.
20. Woods RP, Iacoboni M, Mazziotta JC Bilateral spreading cerebral hypoperfusion during spontaneous migraine headaches. N Eng J Med 1994, 331:1689-1692.
21. Barkley GL, Tepley N, Nagel L, et al. Magnetoencephalographic studies of migraine. Headache 1990, 30:428-434.
22. Bowyer SM, Aurora KS, Moran JE, Tepley N, Welch KM Magnetoencephalographic fields from patients with spontaneous and induced migraine aura. Ann Neurol 2001, 50:582-587.
23. Aurora SK, Cao Y, Bowyer SM, Welch KM The occipital cortex is hyperexcitable in migraine: Experimental evidence. Headache 1999, 39:469-476.
24. Young WB, Oshinsky ML, Shechter AL, Wassermann EM Consecutive transcranial magnetic stimulation induced phosphene thresholds in migraineurs and controls. Neurology 2001, 56:A142. (abstract).
25. Afra J, Mascia A, Gerard P, DeNoordhout AM, Schoenen J Interictal cortical excitability in migraine: A study using transcranial magnetic stimulation of motor and visual cortices. Ann Neurol 1998, 44:209-215.
26. Schoenen J, Thomsen LL Neurophysiology and autonomic dysfunction in migraine. The Headaches 2000, 301-312. Lippincott Williams & Wilkins, Philadelphia. 2nd ed. J. Olesen, P. Tfelt-Hansen, K.M.A. Welch (Eds.).
27. Uddman R, Edvinsson L, Ekman R, Kingman T, McCulloch J Innervation of the feline cerebral vasculature by nerve fibers containing calcitonin gene-related peptide: Trigeminal origin an co-existence with substance P. Neurosci Lett 1985, 62:131-136.
28. Buzzi MG, Moskowitz MA, Shimizu T, Heath HH Dihydroergotamine and sumatriptan attenuate levels of CGRP in plasma in rat superior sagittal sinus during electrical stimulation of the trigeminal ganglion. Neuropharmacology 1991, 30:1193-1200.
29. Markowitz S, Saito K, Moskowitz MA Neurogenically mediated plasma extravasation in dura mater: Effect of ergot alkaloids. A possible mechanism of action in vascular headache. Cephalalgia 1988, 8:83-91.
30. Dimitriadou V, Buzzi MG, Theoharides TC, Moskowitz MA Ultrastructural evidence for neurogenically mediated changes in blood vessels of the rat aura mater and tongue following antidromic trigeminal stimulation. Neuroscience 1992, 48:187-203.
31. Pappagalo M, Szabo Z, Esposito G, Lokesh A, Velez L Imaging neurogenic inflammation inpatients with migraine headaches. Neurology 2002, 52:274-275.
32. Strassman AM, Raymond SA, Burstein R Sensitization of meningeal sensory neurons and the origin of headaches. Nature 1996, 384:560-564.
33. Moskowitz MA, Cutrer FM Sumatriptan: A receptor-targeted treatment for migraine. Ann Rev Med 1993, 44:145-154.
34. Nozaki K, Boccalini P, Moskowitz MA Expression of c-fos-like immunoreactivity in brainstem after meningeal irritation by blood in the subarachnoid space. Neuroscience 1992, 49:669-680.
35. Kaube H, Keay K, Hoskin KL, Bandler R, Goadsby PJ Expression of c-fos like immunoreactivity in the trigeminal nucleus caudalis and high cervical cord following stimulation of the sagittal sinus in the cat. Brain Res 1993, 629:95-102.
36. Goadsby PJ, Hoskin KL The distribution of trigeminovascular afferents in the non-human primate brain. J Anat 1997, 190:367-375.
37. Burstein R, Collins B, Bajwa Z, Jakubowski M Triptan therapy can abort migraine attacks if given before the establishment or in the absence of cutaneous allodynia and central sensitization: Clinical and preclinical evidence. Headache 2002, 42:390-391 (abstract).
38. Burstein R, Cutrer MF, Yarnitsky D The development of cutaneous allodynia during a migraine attack: Clinical evidence for the sequential recruitment of spinal and supraspinal nociceptive neurons in migraine. Brain 2001, 123:1703-1709.
39. Weiller C, May A, Limmroth V, et al. Brainstem activation in spontaneous human migraine attacks. Nat Med 1995, 1:658-660.
40. Bahra A, Matharu MS, Buchel C, Frackowiak RS, Goadsby PJ Brainstem activation specific to migraine headache. Lancet 2001, 357:1016-1017.
41. Bolay H, Reuter U, Dunn AK, et al. Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model. Nat Med 2002, 8:136-142.
42. Kandere-Grzybowska K, Gheorghe D, Priller J, et al. Stress-induced dura vascular permeability does not develop in mast cell-deficient and neurokinin-1 receptor knockout mice. Brain Res 2003, 980:213-220.
43. Hoyer D, Clarke DE, Fozard JR, et al. VII International union of pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol Rev 1994, 46:157-203.
44. Hartig PR, Hoyer D, Humphrey PPA, Martin GR Alignment of receptor nomenclature with the human genome: Classification of 5HT1B and 5HT1D receptor subtypes. Trends Pharmacol Sci 1996, 17:103-105.
45. Longmore J, Shaw D, Smith D, et al. Differential distribution of 5HT(1D)- and 5HT(1B)-immunoreactivity within the human trigeminocerebrovascular system: Implications for the discovery of new antimigraine drugs. Cephalalgia 1997, 17:833-842.
46. Buzzi MG, Sakas DE, Moskowitz MA Indomethacin and acetyl salicylic acid block neurogenic plasma protein extravasation in rat dura mater. Eur J Pharmacol 1989, 165:251-258.
47. Cutrer FM, Limmroth V, Ayata G, Moskowitz MA Attenuation by valproate of c-fos immunoreactivity in trigeminal nucleus caudalis induced by intracisternal capsaicin. Br J Pharmacol 1995, 116:3199-3204.
48. Lee WS, Limmroth V, Ayata C, et al. Peripheral GABA-A receptor mediated effects of sodium valproate on dural plasma protein extravasation to substance P and trigeminal stimulation. Br J Pharmacol 1995, 116:1661-1667.
49. Limmroth V, Lee WS, Cutrer FM, Moskowitz MA GABAA-receptor-mediated effects of progesterone, its ring-A-reduced metabolites and synthetic neuroactive steroids on neurogenic edema in the rat meninges. Br J Pharmacol 1996, 117:99-104.
50. Lee WS, Moussaoui SM, Moskowitz MA Blockade by oral or parenteral RPR100893 (a nonpeptide NK1 receptor antagonist) of neurogenic plasma protein extravasation in guinea-pig dura mater and conjunctiva. Br J Pharmacol 1994, 112:920-924.
51. May A, Gijsman HJ, Wallnoefer A, et al. Endothelin antagonist bosentan blocks neurogenic inflammation, but is not effective in aborting migraine attacks. Pain 1996, 67:375-378.
52. 3H]-dihydroergotamine binding sites in the cat central nervous system: relevance to migraine. Ann Neurol 1991, 29:91-94.
53. Lipton RB, Hamelsky SW, Stewart WF Epidemiology and impact of headache. Wolff's Headache and Other Head Pain 2001, 85-107. Oxford University Press, New York. 7th ed. S.D. Silberstein, R.B. Lipton, D.J. Dalessio (Eds.).
54. Lance JW, Anthony M Some clinical aspects of migraine. Arch Neurol 1966, 15:356-361.
55. Silberstein SD Headaches, pregnancy, and lactation. Drug Therapy in Pregnancy 2001, 231-254. Lippincott Williams & Wilkins, Philadelphia. 3rd ed. J. Yankowitz, J.R. Niebyl (Eds.).
56. Silberstein SD Migraine, pregnancy, lactation. Neurologic Disorders in Pregnancy 2004, Parthenon, New York. J.M. Washington (Ed.).
57. Evans RW, Lipton RB, Silberstein SD The prevalence of migraine in neurologists. Neurology 2003, 61:1271-1272.
58. Silberstein SD Transformed and chronic migraine. Chronic Daily Headache for Clinicians 2005, 21-56. Decker, Hamilton, BC. P.J. Goadsby, S.D. Silberstein, D.W. Dodick (Eds.).
59. Lyngberg AC, Rasmussen BK, Jorgensen T, Jensen R Prognosis of migraine and tension-type headache: A population-based follow-up study. Neurology 2005, 65:580-585.
60. Silberstein SD, Lipton RB, Breslau N Migraine: Association with personality characteristics and psychopathology. Cephalalgia 1995, 15:337-369.
61. Breslau N, Davis GC Migraine, major depression and panic disorder: A prospective epidemiologic study of young adults. Cephalalgia 1992, 12:85-89.
62. Breslau N, Lipton RB, Stewart WF, Schultz LR, Welch KM Comorbidity of migraine and depression: Investigating potential etiology and prognosis. Neurology 2003, 60:1308-1312.
63. Gaist D, Pedersen L, Madsen C, et al. Long-term effects of migraine on cognitive function: A population-based study of Danish twins. Neurology 2005, 64:600-607.
64. Blau JN Migraine prodromes separated from the aura: Complete migraine. Br Med J 1980, 281:658-660.
65. Giffin NJ, Ruggiero L, Lipton RB, et al. Premonitory symptoms in migraine: An electronic diary study. Neurology 2003, 60:935-940.
66. Giffin NJ, Ruggiero L, Lipton RB, et al. A novel approach to the study of premonitory symptoms in migraine using an electronic diary. Neurology 2003, 60:935-940.
67. Silberstein SD Migraine. Lancet 2004, 363:381-391.
68. Silberstein SD, Young WB Migraine aura and prodrome. Semin Neurol 1995, 45:175-182.
69. Selby G, Lance JW Observation on 500 cases of migraine and allied vascular headaches. J Neurol Neurosurg Psychiatry 1960, 23:23-32.
70. Silberstein SD Migraine symptoms: Results of a survey of self-reported migraineurs. Headache 1995, 35:387-396.
71. Bradshaw P, Parsons M Hemiplegic migraine, a clinical study. Q J Med 1965, 34:65-85.
72. Thomsen LL, Ostergaard E, Olesen J, Russell MB Evidence for a separate type of migraine with aura: Sporadic hemiplegic migraine. Neurology 2003, 60:595-601.
73. 2+ channel gene CACNLA4. Cell Tiss Res 1996, 87:543-552.
74. Joutel A, Bousser MG, Biousee V A gene for familial hemiplegic migraine maps to chromosome 19. Nat Genet 1993, 5:40-45.
75. Ducros A, Deiner C, Joutel A, et al. The clinical spectrum of familial hemiplegic migraine associated with mutations in a neuronal calcium channel. N Engl J Med 2001, 345:17-24.
76. Ferrari MD, Haan J Genetics of headache. Wolff's Headache and Other Head Pain 2001, 73-84. Oxford University Press, New York. 7th ed. S.D. Silberstein, R.B. Lipton, D.J. Dalessio (Eds.).
77. De Fusco M, Marconi R, Silvestri L, et al. Haploinsufficiency of ATP1A2 encoding the Na(+)/K(+) pump alpha2 subunit associated with familial hemiplegic migraine type 2. Nat Genet 2003, 33:192-196.
78. Moskowitz MA, Bolay H, Dalkara T Deciphering migraine mechanisms: Clues from familial hemiplegic migraine genotypes. Ann Neurol 2004, 55:276-280.
79. Fisher CM Late life migraine accompaniments as a cause of unexplained transient ischemic attacks. Can J Neurol Sci 1980, 7:9-17.
80. Tournier-Lasserve E, Joutel A, Melki J Cerebral autosomal arteriopathy with subcortical infarcts and leukoencephalopathy maps to chromosomes. Nat Genet 1993, 3:256-259.
81. Joutel A, Vahedi K, Corpechot C, et al. Strong clustering and stereotyped nature of Notch3 mutations in CADASIL patients. Lancet 1997, 350:1511-1515.
82. Joutel A, Corpechot C, Ducros A, et al. Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia. Nature 1996, 383:707-710.
83. Marks DA, Ehrenberg BL Migraine related seizures in adults with epilepsy, with EEG correlation. Neurology 1993, 43:2476-2483.
84. Frishberg BM The utility of neuroimaging in the evaluation of headache in patients with normal neruologic exminations. Neurology 1994, 4:1191-1197.
85. Ramadan NM, Silberstein SD, Freitag FG, Gilbert TT, Frishberg B Evidence-based guidelines of the pharmacological management for prevention of migraine for the primary care provider. Neurology [serial online] 1999, Available at. http://www.neurology.org.
86. Matchar DB, Young WB, Rosenberg JA, et al. Evidence-based guidelines for migraine headache in the primary care setting: pharmacological management of acute attacks. Neurology [serial online] 2000, Available at. http://www.neurology.org.
87. Silberstein SD, Lipton RB Overview of diagnosis and treatment of migraine. Neurology 1994, 44:6-16.
88. Lipton RB, Stewart WF, Stone AM, Lainez MJ, Sawyer JP Stratified care vs step care strategies for migraine. The disability in strategies of care (DISC) study: A randomized trial. JAMA 2000, 284:2599-2605.
89. Silberstein SD, Goadsby PJ Migraine: preventive treatment. Cephalalgia 2002, 22:491-512.
90. Cady RK, Sheftell F, Lipton RB, et al. Effect of early intervention with sumatriptan on migraine pain: Retrospective analyses of data from three clinical trials. Clin Therap 2000, 22:1035-1048.
91. Silberstein SD, Saper JR, Freitag F Migraine: Diagnosis and treatment. Wolff's Headache and Other Head Pain 2001, 121-237. Oxford University Press, New York. 7th ed. S.D. Silberstein, R.B. Lipton, D.J. Dalessio (Eds.).
92. Silberstein SD, Neto W, Schmitt J, Jacobs D Topiramate in migraine prevention: Results of a large controlled trial. Arch Neurol 2004, 61:490-495.
93. Silberstein SD, Lipton RB, Goadsby PJ Migraine: Diagnosis and treatment. Headache in Clinical Practice 1998, 61-90. Isis Medical Media, Oxford. S.D. Silberstein, R.B. Lipton, P.J. Goadsby (Eds.).
94. Silberstein SD, Mathew N, Saper J, Jenkins S Botulinum toxin type A as a migraine preventive treatment. Headache 2000, 40:445-450.
95. Mathew NT, Frishberg BM, Gawel M, et al. Botulinum toxin type A (Botox) for the prophylactic treatment of chronic daily headache: A randomized, double-blind, placebo-controlled trial. Headache 2005, 45:293-307.
96. Dodick DW, Mauskop A, Elkind AH, et al. Botulinum toxin type A for the prophylaxis of chronic daily headache: Subgroup analysis of patients not receiving other prophylactic medications: A randomized double-blind, placebo-controlled study. Headache 2005, 45:315-324.
97. Olesen J Clinical and pathophysiological observations in migraine and tension-type headache explained by integration of vascular, supraspinal and myofascial inputs. Pain 1991, 46:125-132.
98. Silberstein SD Chronic daily headache and tension-type headache. Neurology 1993, 43:1644-1649.
99. Bakshi R, Mechtler LL, Kamran S, et al. MRI findings in lumbar puncture headache syndrome: Abnormal dural-meningeal and dural venous sinus enhancement. Clin Imaging 1999, 23:73-76.
100. Pakiam AS, Lee C, Lang AE Intracranial hypotension with parkinsonism, ataxia, and bulbar weakness. Arch Neurol 1999, 56:869-872.
101. Mokri B, Piepgras DG, Miller GM Syndrome of orthostatic headaches and diffuse pachymeningeal gadolinium enhancement. Mayo Clin Proc 1997, 72:400-413.
102. Rabin BM, Roychowdhury S, Meyer JR, et al. Spontaneous intracranial hypotension: Spinal MR findings. Am J Neuroradiol 1998, 19:1034-1039.
103. Fromm GH, Graff-Radford SB, Terrence CF, Sweet WH Pretrigeminal neuralgia. Neurology 1990, 40:1493-1495.
104. Lipton RB, Stewart WF, Cady R, et al. Sumatriptan for the range of headaches in migraine sufferers: Results of the spectrum study. Headache 2000, 40:783-791.
105. Goadsby PJ, Edvinsson L Human in vivo evidence for trigeminovascular activation in cluster headache. Brain 1994, 117:427-434.
106. May A, Bahra A, Buchel C, Frackowiak RS, Goadsby PJ Hypothalamic activation in cluster headache attacks. Lancet 1998, 352:275-278.
107. Silberstein SD Pharmacological management of cluster headache. CNS Drugs 1994, 2:199-207.
108. Manzoni GC Male preponderance of cluster headache is progressively decreasing over the years. Headache 1997, 37:588-589.
109. Manzoni GC Cluster headache and lifestyle: Remarks on a population of 374 male patients. Cephalalgia 1999, 19:88-94.
110. Manzoni GC, Prusinski A Cluster headache: Introduction. The Headaches 2000, 675-678. Lippincott Williams & Wilkins, Philadelphia. 2nd ed. J. Olesen, P. Tfelt-Hansen, K.M.A. Welch (Eds.).
111. Silberstein SD, Niknam R, Rozen TD, Young WB Cluster headache with aura. Neurology 2000, 54:219-221.
112. Jarrar RG, Black DF, Dodick DW, Davis DH Outcome of trigeminal nerve section in the treatment of chronic cluster headache. Neurology 2003, 60:1360-1362.
113. Ford RG, Ford KT, Swaid S, et al. Gamma knife treatment of refractory cluster headache. Headache 1998, 38:1-9.
114. Leone M, Franzini A Stereotactic stimulation of the posterior hypothalamic gray matter in a patient with intractable cluster headache. N Engl J Med 2001, 345:1428-1429.
115. Russell D, Vincent M Chronic paroxysmal hemicrania. The Headaches 2000, 741-750. Lippincott Williams & Wilkins, Philadelphia. 2nd ed. J. Olesen, P. Tfelt-Hansen, K.M.A. Welch (Eds.).
116. King JO, Mitchell PJ, Thomson KR, Tress BM Cerebral venography and manometry in idiopathic intracranial hypertension. Neurology 1995, 45:2224-2228.
117. Mokri B Headache associated with abnormalities in intracranial structure or function: low cerebrospinal fluid pressure headache. Wolff's Headache and Other Head Pain 2001, 417-433. Oxford University Press, New York. 7th ed. S.D. Silberstein, R.B. Lipton, D.J. Dalessio (Eds.).
118. Malm J, Kristensen B, Markgren P, Ekstedt J CSF hydrodynamics in idiopathic intracranial hypertension: A long-term study. Neurology 1992, 42:851-858.
119. Farb RI, Vanek I, Scott JN, et al. Idiopathic intracranial hypertension: the prevalence and morphology of sinovenous stenosis. Neurology 2003, 60:1418-1424.
120. Silberstein SD, McKinstry RC The death of idiopathic intracranial hypertension?. Neurology 2003, 60:1406-1407.
121. Friedman DI, Jacobson DM Diagnostic criteria for idiopathic intracranial hypertension. Neurology 2002, 59:1492-1495.
122. Mokri B Spontaneous intracranial hypotension. Curr Neurol Neurosci Rep 2001, 1:109-117.
123. Lay CL, Campbell JK, Mokri B Low cerebrospinal fluid pressure headache. Headache 1997, 355-368. Butterworth-Heinemann, Boston. P.J. Goadsby, S.D. Silberstein (Eds.).
124. Kleyweg RP, Hertzberger LI, Carbaat PA Significant reduction in post-lumbar puncture headache using an atraumatic needle. A double-blind, controlled clinical trial. Cephalalgia 1998, 18:635-637.
125. Kasner SE, Rosenfield J, Farber RE Spontaneous intracranial hypotension: Headache with a reversible Arnold-Chiari malformation. Headache 1995, 35:557-559.
126. Atkinson JL, Weinshenker BG, Miller GM, Piepgras DG, Mokri B Acquired Chiari I malformation secondary to spontaneous cerebrospinal fluid leakage and chronic intracranial hypotension syndrome in seven cases. J Neurosurg 1998, 88:237-242.
127. Mokri B, Atkinson JL, Dodick DW, Miller GM, Piepgras DG Absent pachymeningeal gadolinium enhancement on cranial MRI despite symptomatic CSF leak. Neurology 1999, 53:402-404.
128. Moayeri NN, Henson JW, Schaefer PW, Zervas NT Spinal dural enhancement on magnetic resonance imaging associated with spontaneous intracranial hypotension. Report of three cases and review of the literature. J Neurosurg 1998, 88:912-918.
129. Waguri N, Tomita M, Hayatsu K, Okamoto K, Shimoji K Epidural blood patch for treatment of spontaneous intracranial hypotension. Acta Anaesthesiol Scand 2002, 46:747-750.
130. Bart AJ, Wheeler AS Comparison of epidural saline infusion and epidural blood placement in the treatment of post lumbar puncture headache. Anesthesiology 1978, 48:221-223.
131. Kantor D, Silberstein SD Cervical epidural blood patch for low CSF pressure headaches. Neurology 2005, 65:1138.
132. Forsyth PA, Posner JB Headaches in patients with brain tumors. A study of 111 patients. Neurology 1993, 43:1678-1683.
133. Symonds C Cough headache. Brain 1956, 79:557-568.
134. Rooke ED Benign exertional headache. Med Clin North Am 1968, 52:801-808.
135. Rasmussen BK, Jensen R, Schroll M, Olesen J Epidemiology of headache in a general population-A prevalence study. J Clin Epidemiol 1991, 44:1147-1157.
136. Sands GH, Newman L, Lipton R Cough, exertional, and other miscellaneous headaches. Med Clin North Am 1991, 75:733-746.
137. Pascual J, Iglesias F, Oterino A, Vazquez-Barquero A Cough, exertional, and sexual headaches: An analysis of 72 benign and symptomatic cases. Neurology 1996, 46:1520-1524.
138. Raskin NH The indomethacin-responsive syndromes. Headache 1988, 255-268. Churchill Livingstone, New York. N.H. Raskin (Ed.).
139. Silbert PL, Edis RH, Stewart-Wynne EG, Gubbay SS Benign vascular sexual headache and exertional headache: Interrelationships and long term prognosis. J Neurol Neurosurg Psychiatry 1991, 54:417-421.
140. Rasmussen KR, Olesen J Symptomatic and nonsymptomatic headaches in a general population. Neurology 1992, 42:1225-1231.
141. Valenca MM, Valenca LP, Bordini CA, et al. Cerebral vasospasm and headache during sexual intercourse and masturbatory orgasms. Headache 2004, 44:244-248.
142. Johns DR Benign sexual headache within a family. Arch Neurol 1986, 43:1158-1160.
143. Adams HP, Kassell NF, Torner JC, Sahs AL CT and clinical correlations in recent aneurysmal subarachnoid hemorrhage: A preliminary report of the cooperative aneurysm study. Neurology 1983, 33:981-988.
144. Day JW, Raskin NH Thunderclap headache: Symptom of unruptured cerebral aneurysm. Lancet 1986, 1247-1248.
145. Ng PK, Pulst SM Not so benign "thunderclap headache.". Neurology 1992, 260:42.
146. Raps EC, Rogers JD, Galetta SL, et al. The clinical spectrum of unruptured intracranial aneurysms. Arch Neurol 1993, 50:265-268.
147. Dodick DW Thunderclap headache. Headache 2002, 42:309-315.
148. Hansen SL, Borelli-Miller L, Strange P, Nielson BM, Elusion J Opthalmoplegic migraine: Diagnostic criteria, incidence of hospitalization and possible etiology. Acta Neurol Scand 1990, 81:54-60.
149. Mark AS, Casselman J, Brown D, et al. Ophthalmoplegic migraine: Reversible enhancement and thickening of the cisternal segment of the oculomotor nerve on contrast-enhanced MR images. Am J Neuroradiol 1998, 19:1887-1891.
150. Nelson JA, Wolfe MD, Yuh WT, Peeples ME Cranial nerve involvement with Lyme borreliosis demonstrated by magnetic resonance imaging. Neurology 1992, 42(Suppl 3, Part 1):673.
151. Pachner AR, Duray P, Steere AC Central nervous system manifestations of Lyme disease. Arch Neurol 1989, 46:790-795.
152. Blake PY, Mark AS, Kattah J, Kolsky M MR of oculomotor nerve palsy. Am J Neuroradiol 1995, 16:241-251.
153. Schmitt T, Erbguth F, Taghavy A Oculomotor paralysis as the leading symptom of meningovascular syphilis: Report of two patients and review of the literature. Nervemarzt 1993, 64:668-672.
154. May M Idiopathic (Bell's) palsy, herpes zoster and other facial nerve disorders of viral origin. The Facial Nerve 1986, 365-399. Thieme, New York. M. May (Ed.).
155. Yanguela J, del Rio M Sanchez, Bueno A, et al. Primary trochlear headache: A new cephalgia generated and modulated on the trochlear region. Neurology 2004, 62:1134-1140.
156. Silberstein SD Nose and sinus-related headaches 1995, Arbor, La Jolla, CA.
157. Jannetta PJ Arterial compression of the trigeminal nerve at the pons in patients with trigeminal neuralgia. J Neurosurg 1967, 26:159-162.
158. Zakrzewska JM Trigeminal neuralgia. Major Problems in Neurology 1995, 108-170. Saunders, London. J.M. Zakrzewska (Ed.).
159. Kondziolka D, Lunsford LD, Habeck M, Flickinger JC Gamma knife radiosurgery for trigeminal neuralgia. Neurosurg Clin North Am 1997, 8:79-85.
160. Edmeads JG Disorders of the neck: Cervicogenic headache. Wolff's Headache and Other Head Pain 2001, 447-458. Oxford University Press, New York. 7th ed. S.D. Silberstein, R.B. Lipton, D.J. Dalessio (Eds.).
161. Bogduk N Cervicogenic headache: Anatomic basis and pathophysiologic mechanisms. Curr Pain Headache Rep 2001, 5:382-386.
162. Rushton JG, Stevens JC, Miller RH Glossopharyngeal (vagoglossopharyngeal) neuralgia. Arch Neurol 1981, 38:201-205.
163. Young WB, Silberstein SD Headache in the elderly. Principles and Practice of Geriatric Medicine 1998, 733-746. John Wiley & Sons, West Sussex, UK. 3rd ed. M.S. Pathy (Ed.).
164. Bousser MG, Good J, Kittner ST, Silberstein SD Headache associated with vascular disorders. Wolff's Headache and Other Head Pain 2001, 349-392. Oxford University Press, New York. 7th ed. S.D. Silberstein, R.B. Lipton, D.J. Dalessio (Eds.).
165. Chabriat H, Tournier-Lasserve E, Vahedi K, et al. Autosomal dominant migraine with MRI white-matter abnormalities mapping to the CADASIL locus. Neurology 1995, 45:1086-1091.
166. Bigal ME, Liberman JN, Lipton RB Age-dependent prevalence and clinical features of migraine. Neurology 2006, 67:246-251.
167. Dahlöf C Integrating the triptans into clinical practice. Curr Opin Neurol 2002, 15:317-322.
168. Kirchmann M, Thomsen L Lykke, Olesen J Basilar-type migraine: Clinical, epidemiologic, and genetic features. Neurology 2006, 66:880-886.
169. Mechanism and Management of Headache 2005, Elsevier, Butterworth-Heinemann, Philadelphia. 7th ed.
170. Lipton RB, Silberstein SD Comorbidity of migraine. Neurology 1994, 44(Suppl 7):S4-S5.
171. The Headaches 2001, Raven Press, New York. 2nd ed.
172. Appropriate use of ergotamine and dihydroergotamine (DHE) in the treatment of migraine and status migrainosus 1994, 225-228. Quality Standards Subcommittee, AAN Practice Handbook.
173. Silberstein SD Practice parameter: Evidence-based guidelines for migraine headache (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2000, 55:754-763.
174. Headache in clinical practice 2002, Martin Dunitz, New York.
175. Wolff's Headache and Other Head Pain 2001, Oxford University Press, New York. 7th ed.
176. Wammes-van der Heijden EA, Rahimtoola H, Leufkens HGM, et al. Risk of ischemic complications related to the intensity of triptan and ergotamine use. Neurology 2006, 67:1128-1134.
177. Interactive study questions and referenced videos for this chapter are available on the DVD-ROM.